• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep30
Distribution Plan(EST)

Cash dividend 0.0098 USD

Sep23
Distribution Plan(EST)

Cash dividend 0.0098 USD

Distribution Plan(EST)

Cash dividend 0.0098 USD

View More

Event Tracking

Dec18
Eli Lilly Initiates Phase III Clinical Trial of Retatrutide for Metabolic-Associated Fatty Liver Disease in China
04:51
Eli Lilly lowers prices for best-selling diabetes and weight-loss drugs in Canada
00:00
Lilly Announces Phase 3 EMBER-3 Trial Results for Imlunestrant in Breast Cancer Patients
00:00
Eli Lilly's partner in China, Innovent, published Phase 3 clinical results for Mazdutide in Type 2 Diabetes in the journal Nature.
00:00
Dec17
Eli Lilly Garners Attention for a "Trio" of Achievements in Alzheimer's, Obesity, and Cancer
23:12
Eli Lilly partners with the 2026 Winter Olympics, sponsors the US team and donates to non-profit organizations for health equity
21:57